These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Editorial: Advances in understanding the pathogenesis of and designing therapies for connective tissue disease-associated interstitial lung disease. Duan L; Yang Y; Zhu X Front Immunol; 2023; 14():1295647. PubMed ID: 37908365 [No Abstract] [Full Text] [Related]
23. [Research progress of serum biomarkers in interstitial lung disease associated with connective tissue disease]. Liang J; Chen YL; Lu RL; Guo JW; Hong XP; Liu DZ Zhonghua Nei Ke Za Zhi; 2024 Mar; 63(3):310-315. PubMed ID: 38448195 [TBL] [Abstract][Full Text] [Related]
25. Safety data from the use of antifibrotics in connective tissue disease-related interstitial lung disease: particular emphasis on association with immunosuppression. Duarte AC; Cordeiro A; Lopes M; Soares J; Santos MJ ARP Rheumatol; 2023; 2(1):88-91. PubMed ID: 36739564 [No Abstract] [Full Text] [Related]
26. COVID-19 in Patients With Connective Tissue Disease-related Interstitial Lung Disease. Truong L; Pourzand L; Volkmann ER J Rheumatol; 2021 Mar; 48(3):468-470. PubMed ID: 32934125 [No Abstract] [Full Text] [Related]
27. Azathioprine for Connective Tissue Disease-Associated Interstitial Lung Disease: In Search for Evidence-Based Medicine. Tzilas V; Kahn N; Bouros D Respiration; 2020; 99(11):930-931. PubMed ID: 33022675 [No Abstract] [Full Text] [Related]
30. The development of connective tissue diseases in patients with autoimmune hepatitis: a case series. West M; Jasin HE; Medhekar S Semin Arthritis Rheum; 2006 Jun; 35(6):344-8. PubMed ID: 16765710 [TBL] [Abstract][Full Text] [Related]
31. [Diagnostic difficulties in polymyositis]. Majewski D; Puszczewicz M; Tuchocka-Piotrowska A; Kołczewska A Ann Acad Med Stetin; 2006; 52 Suppl 2():45-8. PubMed ID: 17474177 [TBL] [Abstract][Full Text] [Related]